Ascentage Pharma Group International (AAPG) Cash from Financing Activities (2025)
Powered by 
Analysis
Ascentage Pharma Group International (AAPG) Cash from Financing Activities (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | 14.00 Mn |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | 2.42 Bn |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | -6.05 Mn |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | 36.24 Mn |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | -273.15 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Ascentage Pharma Group International | 1.57 Bn | 1.29 Bn | - | - |